These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21098022)

  • 1. Amino acid residues constituting the agonist binding site of the human P2X3 receptor.
    Bodnar M; Wang H; Riedel T; Hintze S; Kato E; Fallah G; Gröger-Arndt H; Giniatullin R; Grohmann M; Hausmann R; Schmalzing G; Illes P; Rubini P
    J Biol Chem; 2011 Jan; 286(4):2739-49. PubMed ID: 21098022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational flexibility of the agonist binding jaw of the human P2X3 receptor is a prerequisite for channel opening.
    Kowalski M; Hausmann R; Dopychai A; Grohmann M; Franke H; Nieber K; Schmalzing G; Illes P; Riedel T
    Br J Pharmacol; 2014 Nov; 171(22):5093-112. PubMed ID: 24989924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
    Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
    Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors.
    Hausmann R; Bodnar M; Woltersdorf R; Wang H; Fuchs M; Messemer N; Qin Y; Günther J; Riedel T; Grohmann M; Nieber K; Schmalzing G; Rubini P; Illes P
    J Biol Chem; 2012 Apr; 287(17):13930-43. PubMed ID: 22378790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
    Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
    Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nucleotide analogs at the P2X3 receptor and its mutants identify the agonist binding pouch.
    Riedel T; Wiese S; Leichsenring A; Illes P
    Mol Pharmacol; 2012 Jul; 82(1):80-9. PubMed ID: 22498660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved lysin and arginin residues in the extracellular loop of P2X(3) receptors are involved in agonist binding.
    Fischer W; Zadori Z; Kullnick Y; Gröger-Arndt H; Franke H; Wirkner K; Illes P; Mager PP
    Eur J Pharmacol; 2007 Dec; 576(1-3):7-17. PubMed ID: 17764672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP.
    Vacca F; D'Ambrosi N; Nestola V; Amadio S; Giustizieri M; Cucchiaroni ML; Tozzi A; Velluz MC; Mercuri NB; Volonté C
    Glycobiology; 2011 May; 21(5):634-43. PubMed ID: 21186285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X1 receptor.
    Marquez-Klaka B; Rettinger J; Bhargava Y; Eisele T; Nicke A
    J Neurosci; 2007 Feb; 27(6):1456-66. PubMed ID: 17287520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP binding at human P2X1 receptors. Contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists.
    Roberts JA; Evans RJ
    J Biol Chem; 2004 Mar; 279(10):9043-55. PubMed ID: 14699168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel.
    Stephan G; Huang L; Tang Y; Vilotti S; Fabbretti E; Yu Y; Nörenberg W; Franke H; Gölöncsér F; Sperlágh B; Dopychai A; Hausmann R; Schmalzing G; Rubini P; Illes P
    Nat Commun; 2018 Apr; 9(1):1354. PubMed ID: 29636447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist antagonist interactions at the rapidly desensitizing P2X3 receptor.
    Helms N; Kowalski M; Illes P; Riedel T
    PLoS One; 2013; 8(11):e79213. PubMed ID: 24223907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional differences between ATP-gated human and rat P2X3 receptors are caused by critical residues of the intracellular C-terminal domain.
    Sundukova M; Vilotti S; Abbate R; Fabbretti E; Nistri A
    J Neurochem; 2012 Aug; 122(3):557-67. PubMed ID: 22639984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.
    Shcherbatko A; Foletti D; Poulsen K; Strop P; Zhu G; Hasa-Moreno A; Melton Witt J; Loo C; Krimm S; Pios A; Yu J; Brown C; Lee JK; Stroud R; Rajpal A; Shelton D
    J Biol Chem; 2016 Jun; 291(23):12254-70. PubMed ID: 27129281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the ectodomain serine 275 in shaping the binding pocket of the ATP-gated P2X3 receptor.
    Petrenko N; Khafizov K; Tvrdonova V; Skorinkin A; Giniatullin R
    Biochemistry; 2011 Oct; 50(39):8427-36. PubMed ID: 21879712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors.
    Allsopp RC; Lalo U; Evans RJ
    J Biol Chem; 2010 Oct; 285(43):32770-32777. PubMed ID: 20699225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors.
    Asatryan L; Popova M; Woodward JJ; King BF; Alkana RL; Davies DL
    Neuropharmacology; 2008 Oct; 55(5):835-43. PubMed ID: 18639563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons.
    Liu M; King BF; Dunn PM; Rong W; Townsend-Nicholson A; Burnstock G
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1043-50. PubMed ID: 11181939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
    Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.